Veracyte
VCYT
#3651
Rank
HK$27.45 B
Marketcap
HK$347.27
Share price
-6.01%
Change (1 day)
4.17%
Change (1 year)

Earnings for Veracyte (VCYT)

Earnings in 2025 (TTM): HK$0.19 Billion

According to Veracyte's latest financial reports the company's current earnings are HK$0.49 Billion. In 2024 the company made an earning of HK$0.18 Billion, an increase over its 2023 earnings that were of -HK$0.6 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Veracyte from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$0.19 B3.07%
2024 HK$0.18 B-131.34%
2023 -HK$0.6 Billion111.42%
2022 -HK$0.29 Billion-55.5%
2021 -HK$0.64 Billion134.74%
2020 -HK$0.27 Billion190.89%
2019 -HK$92.81 Million-43.33%
2018 -HK$0.17 Billion-23.78%
2017 -HK$0.22 Billion-3.51%
2016 -HK$0.23 Billion-14.17%
2015 -HK$0.26 Billion15.17%
2014 -HK$0.23 Billion14.15%
2013 -HK$0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exact Sciences
EXAS
-HK$7.56 Billion-4,019.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-HK$0.28 Billion-241.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-HK$3.26 Billion-1,791.18%๐Ÿ‡บ๐Ÿ‡ธ USA